Elizabeth Skippington
Biochemistry, Genetics and Molecular Biology · Indiana University
Publications
43
Citations
2,855
Est. group size
—
Recurring co-author estimate
Active years
17
Publishing since 2010
Elizabeth Skippington works in molecular microbiology and genomics, studying how bacteria cause disease, resist antibiotics, and interact with the human gut. Recent work spans discovering new antibacterial compounds (including through deep-learning-based screening), understanding how pathogens evade host defenses, and analyzing gut bacterial genetics and their role in intestinal health.
After a lower-output period around 2019-2022, publication activity has grown notably, with the most recent years (2024-2025) showing the highest counts of the decade.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- Dictionary of human intestinal organoid responses to secreted niche factors at single cell resolution
Nature Communications · 2026
- The BaeSR two-component system activates <i>bamK</i> , a paralog of the essential β-barrel foldase <i>bamA</i> , in <i>Klebsiella pneumoniae</i>
mBio · 2026
- Deep-learning-based virtual screening of antibacterial compounds
Nature Biotechnology · 2025
- Spatiotemporal Characterization of Sulfasalazine and 5‐ <scp>ASA</scp> Pharmacokinetics Using a Noninvasive Intestinal Sampling Device
Clinical Pharmacology & Therapeutics · 2025
- Enteropathogenic bacteria evade ROCK-driven epithelial cell extrusion
Nature · 2025
- Dysbiosis-associated gut bacterium <i>Ruminococcus gnavus</i> varies at the strain level in its ability to utilize key mucin component sialic acid
Microbiology Spectrum · 2025
- Dictionary of human intestinal organoid responses to secreted niche factors at single cell resolution
bioRxiv (Cold Spring Harbor Laboratory) · 2025
- Tu2043: ASSESSING INTESTINAL LUMINAL SULFASALAZINE LEVELS USING THE ENVIVO CAPSCAN INGESTIBLE SAMPLING DEVICE
Gastroenterology · 2025
- Publisher Correction: Deep-learning-based virtual screening of antibacterial compounds
Nature Biotechnology · 2025
- A record-setting mitogenome in the holoparasitic plant Balanophora yakushimensis accompanied by exceptional loss of organellar DNA repair and recombination genes
BMC Biology · 2025
- Discovery of GuaB inhibitors with efficacy against <i>Acinetobacter baumannii</i> infection
mBio · 2024
- Toxigenic <i>Clostridium perfringens</i> Isolated from At-Risk Paediatric Inflammatory Bowel Disease Patients
Journal of Crohn s and Colitis · 2024
- Differential effects of inosine monophosphate dehydrogenase (IMPDH/GuaB) inhibition in <i>Acinetobacter baumannii</i> and <i>Escherichia coli</i>
Journal of Bacteriology · 2024
- A high-throughput phenotypic screen combined with an ultra-large-scale deep learning-based virtual screening reveals novel scaffolds of antibacterial compounds
bioRxiv (Cold Spring Harbor Laboratory) · 2024
- Dysbiosis-associated gut bacterium <i>Ruminococcus gnavus</i> varies at the strain level in ability to utilize key mucin component sialic acid
bioRxiv (Cold Spring Harbor Laboratory) · 2024
- Proceedings of the National Academy of Sciences×4
- Nature×3
- Nature Communications×3
- mBio×3
- bioRxiv (Cold Spring Harbor Laboratory)×3
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile